Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsies, Myoclonic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT05288283
What this trial is testing

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

Who this might be right for
Seizures Associated With EMAS
Jazz Pharmaceuticals 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT07723963
What this trial is testing

Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

Who this might be right for
Juvenile Myoclonic Epilepsy
Jazz Pharmaceuticals 260
Large-scale testing (Phase 3)Study completedNCT00368251
What this trial is testing

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults

Who this might be right for
Unverricht-Lundborg Disease
UCB Pharma 56
Early research (Phase 1)Study completedNCT05873062
What this trial is testing

Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK

Who this might be right for
Myoclonus Epilepsies, Progressive
Autifony Therapeutics Limited 6
Large-scale testing (Phase 3)Ended earlyNCT03299842
What this trial is testing

Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT02473445
What this trial is testing

A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease

Who this might be right for
Mitochondrial Diseases
Amgen 22
Not applicableUnknownNCT06504511
What this trial is testing

SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom

Who this might be right for
SCN1ADravet SyndromeEpilepsy
NHS Greater Glasgow and Clyde 400
Post-approval studies (Phase 4)Active Not RecruitingNCT05044819
What this trial is testing

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Who this might be right for
Lennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex
Jazz Pharmaceuticals 154
Not applicableApproved For MarketingNCT02660255
What this trial is testing

Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT01607073
What this trial is testing

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Gillette Children's Specialty Healthcare 2
Not applicableLooking for participantsNCT06593951
What this trial is testing

Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)

Who this might be right for
Progressive Myoclonus Epilepsy Type 1EPM1CSTB-related Disease+5 more
Boston Children's Hospital 200
Not applicableLooking for participantsNCT07013331
What this trial is testing

A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome

Who this might be right for
EpilepsyDravet SyndromeDrug Resistant Epilepsy+1 more
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Study completedNCT02023866
What this trial is testing

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

Who this might be right for
Inherited Mitochondrial Disease, Including Leigh Syndrome
Amgen 36
Not applicableStudy completedNCT05544058
What this trial is testing

Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA

Who this might be right for
Dravet Syndrome
Biocodex 100
Early research (Phase 1)UnknownNCT03024827
What this trial is testing

Cannabidiol in Children With Refractory Epileptic Encephalopathy

Who this might be right for
Epileptic Encephalopathy
University of Saskatchewan 20
Post-approval studies (Phase 4)Looking for participantsNCT07112365
What this trial is testing

The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project

Who this might be right for
Dravet Syndrome
The University of Texas Health Science Center, Houston 25
Large-scale testing (Phase 3)Study completedNCT02318602
What this trial is testing

Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

Who this might be right for
Seizures
INSYS Therapeutics Inc 52
Large-scale testing (Phase 3)Study completedNCT02224703
What this trial is testing

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 199
Not applicableAvailableNCT06149663
What this trial is testing

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Who this might be right for
Dravet SyndromeLennox Gastaut SyndromeDevelopmental and Epileptic Encephalopathies
Longboard Pharmaceuticals
Post-approval studies (Phase 4)Not Yet RecruitingNCT06924827
What this trial is testing

Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

Who this might be right for
Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Elizabeth Donner 25
Next Page